€57.30
0.52% day before yesterday
Xetra, Nov 01, 05:35 pm CET
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Carl Zeiss Meditec Target price 2024 - Analyst rating & recommendation

Carl Zeiss Meditec Classifications & Recommendation:

Buy
31%
Hold
50%
Sell
19%

Carl Zeiss Meditec Price Target

Target Price €70.60
Price €57.30
Potential
Number of Estimates 15
15 Analysts have issued a price target Carl Zeiss Meditec 2025 . The average Carl Zeiss Meditec target price is €70.60. This is higher than the current stock price. The highest price target is
€104.00 81.50%
register free of charge
, the lowest is .
A rating was issued by 16 analysts: 5 Analysts recommend Carl Zeiss Meditec to buy, 8 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Carl Zeiss Meditec stock has an average upside potential 2025 of . Most analysts recommend the Carl Zeiss Meditec stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Revenue Billion € 2.09 2.07
9.80% 0.78%
EBITDA Margin 20.92% 15.48%
16.48% 25.99%
Net Margin 13.91% 7.80%
10.03% 43.94%

15 Analysts have issued a sales forecast Carl Zeiss Meditec 2024 . The average Carl Zeiss Meditec sales estimate is

€2.1b
Unlock
. This is
0.53% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€2.1b 2.20%
Unlock
, the lowest is
€2.0b 2.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €2.1b 9.80%
2024
€2.1b 0.78%
Unlock
2025
€2.3b 10.63%
Unlock
2026
€2.5b 7.78%
Unlock
2027
€2.7b 9.08%
Unlock
2028
€2.9b 7.26%
Unlock

15 Analysts have issued an Carl Zeiss Meditec EBITDA forecast 2024. The average Carl Zeiss Meditec EBITDA estimate is

€321m
Unlock
. This is
14.19% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€347m 7.21%
Unlock
, the lowest is
€290m 22.46%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €437m 8.30%
2024
€321m 26.57%
Unlock
2025
€429m 33.70%
Unlock
2026
€508m 18.42%
Unlock
2027
€579m 14.05%
Unlock
2028
€602m 3.89%
Unlock

EBITDA Margin

2023 20.92% 16.48%
2024
15.48% 25.99%
Unlock
2025
18.71% 20.87%
Unlock
2026
20.56% 9.89%
Unlock
2027
21.49% 4.52%
Unlock
2028
20.82% 3.12%
Unlock

12 Carl Zeiss Meditec Analysts have issued a net profit forecast 2024. The average Carl Zeiss Meditec net profit estimate is

€162m
Unlock
. This is
38.06% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€176m 32.76%
Unlock
, the lowest is
€141m 45.89%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €291m 1.22%
2024
€162m 44.35%
Unlock
2025
€206m 27.38%
Unlock
2026
€259m 25.63%
Unlock
2027
€304m 17.39%
Unlock
2028
€368m 20.95%
Unlock

Net Margin

2023 13.91% 10.03%
2024
7.80% 43.94%
Unlock
2025
8.98% 15.13%
Unlock
2026
10.47% 16.59%
Unlock
2027
11.27% 7.64%
Unlock
2028
12.71% 12.78%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Earnings Per Share 3.25 1.81
1.22% 44.31%
P/E 31.68
EV/Sales 2.60

12 Analysts have issued a Carl Zeiss Meditec forecast for earnings per share. The average Carl Zeiss Meditec <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€1.81
Unlock
. This is
38.01% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€1.96 32.88%
Unlock
, the lowest is
€1.58 45.89%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €3.25 1.22%
2024
€1.81 44.31%
Unlock
2025
€2.30 27.07%
Unlock
2026
€2.89 25.65%
Unlock
2027
€3.40 17.65%
Unlock
2028
€4.11 20.88%
Unlock

P/E ratio

Current 19.62 9.36%
2024
31.68 61.47%
Unlock
2025
24.87 21.50%
Unlock
2026
19.80 20.39%
Unlock
2027
16.86 14.85%
Unlock
2028
13.94 17.32%
Unlock

Based on analysts' sales estimates for 2024, the Carl Zeiss Meditec stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.61 24.78%
2024
2.60 0.49%
Unlock
2025
2.35 9.61%
Unlock
2026
2.18 7.22%
Unlock
2027
2.00 8.32%
Unlock
2028
1.86 6.76%
Unlock

P/S ratio

Current 2.49 25.40%
2024
2.47 0.54%
Unlock
2025
2.23 9.61%
Unlock
2026
2.07 7.22%
Unlock
2027
1.90 8.32%
Unlock
2028
1.77 6.77%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today